The beta amyloid peptide (Abeta) is the primary component of the senile plaques observed in the brains of Alzheimer's patients, and this peptide is toxic to neurons and other cells in many different ...

Abeta plaques are found in the brains of patients with Alzheimer’s and are thought to cause the neurological damage that leads to the disease. AC Immune’s share price spiked on the NASDAQ ...

Anti-Abeta antibodies and small molecules for Alzheimer's, targeting amyloid plaques (various trial stages). ACI-24.060 is in 2 phase 2 trials in Alzheimer’s Disease, in collaboration with Takeda.

ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s disease ...